Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00238433. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02268045. IPD Sharing: Not stated. Countries: 12. Publications: 0.
Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00073957. IPD Sharing: NO. Countries: 1. Publications: 0.
GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00521014. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IMPACT Non Hodgkins Lymphoma (NHL) Study
ClinicalTrials.gov study NCT00903812. IPD Sharing: Not stated. Countries: 0. Publications: 4.
17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00117988. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease
ClinicalTrials.gov study NCT01702961. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00299182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT00908180. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00179673. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00051025. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00014560. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of Tenalisib (RP6530), a Novel PI3K δ/γ Dual Inhibitor in Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (iNHL)
ClinicalTrials.gov study NCT03711578. IPD Sharing: NO. Countries: 2. Publications: 0.
PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00303953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
ClinicalTrials.gov study NCT02875067. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00379041. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Ibrutinib and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT02744612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00308087. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT01177397. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00625729. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.